SCHEMBL6465799

SCHEMBL6465799

NC(=O)NCc1cc[c]cc1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.60
CYP2C19 P33261 2/20 0.60
RECQL P46063 1/20 0.49
POLB P06746 1/20 0.43
TPSAB1 Q15661 6/20 0.42
PRSS1 P07477 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
MCL1 Q07820 1/20 0.38
GAA P10253 1/20 0.37
EPHX2 P34913 1/20 0.37
NR1H4 Q96RI1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16935677 0.80 CA1 (0.57) CYP2C9CYP2C19RECQLTPSAB1PRSS1
SCHEMBL8388601 0.79 CYP2C9 (0.66) CYP2C9CYP2C19RECQLPOLBTPSAB1
SCHEMBL754248 0.79 KMT2A (0.58) POLBKMT2AGAA
SCHEMBL2184685 0.79 CYP2C9 (0.37) CYP2C9CYP2C19POLBTPSAB1PRSS1
SCHEMBL81511 0.78 CYP2C19 (0.64) CYP2C9CYP2C19RECQLPOLBCYP1A2
Hydrochloric Acid SCHEMBL8143920 0.78 CYP2C9 (0.63) CYP2C9CYP2C19RECQLPOLBTPSAB1
SCHEMBL16935686 0.77 TPSAB1 (0.58) CYP2C19RECQLTPSAB1TSHRKMT2A
SCHEMBL6390537 0.77 RECQL (0.51) CYP2C9CYP2C19RECQLPOLBTPSAB1
Hydrochloric Acid SCHEMBL17710406 0.77 CYP2C19 (0.62) CYP2C9CYP2C19RECQLPOLBCYP1A2
Benzene SCHEMBL3802036 0.77 CYP2C19 (0.62) CYP2C9CYP2C19RECQLPOLBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1408963-A1 2- 5-(5-CARBAMIMIDOYL-1 i H /i -HETEROARYL)-6-HYDROXYBIPHENYL-3-YL]-SUCCINIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-04-21 EP claimed
WO-2003006011-A1 2-[5-(5-CARBAMIMIDOYL-1H-HETEROARYL)-6-HYDROXYBIPHENYL-3-YL]-SUCCINIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2003-01-23 WO claimed
EP-1569912-A2 2-(2-HYDROXYBIPHENYL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE DERIVATIVES AS FACTOR VIIA INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2005-09-07 EP disclosed
WO-2004050637-A2 2-(2-HYDROXYBIPHENYL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE DERIVATIVES AS FACTOR VIIA INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-06-17 WO disclosed
EP-0885186-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM Dr. Karl Thomae GmbH (DE) 1998-12-23 EP disclosed
WO-1997019911-A1 AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM DR. KARL THOMAE GMBH (DE) 1997-06-05 WO disclosed